Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $9.83 in the prior trading day, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $9.93, up 1.02%. In other words, the price has increased by $1.02 from its previous closing price. On the day, 0.8 million shares were traded. ORIC stock price reached its highest trading level at $9.96 during the session, while it also had its lowest trading level at $9.3728.
Ratios:
Our goal is to gain a better understanding of ORIC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.13 and its Current Ratio is at 16.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on July 08, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.
On September 06, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $20.Stifel initiated its Buy rating on September 06, 2024, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Piscitelli Dominic sold 20,000 shares for $10.05 per share. The transaction valued at 200,972 led to the insider holds 48,317 shares of the business.
Piscitelli Dominic sold 32,466 shares of ORIC for $341,039 on Jun 24 ’25. The Chief Financial Officer now owns 68,317 shares after completing the transaction at $10.50 per share. On Jun 23 ’25, another insider, Piscitelli Dominic, who serves as the Chief Financial Officer of the company, sold 1,034 shares for $10.00 each. As a result, the insider received 10,344 and left with 100,783 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 964431424 and an Enterprise Value of 490280096.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.62, which has changed by 0.06774199 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.67, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -3.21%, while the 200-Day Moving Average is calculated to be 16.94%.
Shares Statistics:
The stock has traded on average 1.37M shares per day over the past 3-months and 795430 shares per day over the last 10 days, according to various share statistics. A total of 86.19M shares are outstanding, with a floating share count of 48.26M. Insiders hold about 50.31% of the company’s shares, while institutions hold 63.89% stake in the company. Shares short for ORIC as of 1753920000 were 6758787 with a Short Ratio of 4.93, compared to 1751241600 on 12580266. Therefore, it implies a Short% of Shares Outstanding of 6758787 and a Short% of Float of 8.05.
Earnings Estimates
ORIC Pharmaceuticals Inc (ORIC) is presently subject to a detailed evaluation by 11.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.28 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.29 and -$2.53 for the fiscal current year, implying an average EPS of -$1.68. EPS for the following year is -$1.66, with 11.0 analysts recommending between -$1.03 and -$2.84.
